Overall, 61 patients were started on a GLP-1 analog, 9 patients were started on an SGLT-2 inhibitor, and 134 were on alternative regimens (controls)
Store the container tightly closed in a cool, dry place
Tirzepatide 15 mg (Mounjaro/Zepbound) produced 22.5% mean weight loss at 72 weeks in SURMOUNT-1 (N=2,539) [14]
Supports natural appetite regulation, eliminating the need for restrictive diets and promoting sustainable weight management
Semaglutide GLP-1 acts on the brains appetite centers, suppressing appetite, reducing food cravings, and increasing feelings of fullness
KrebsHenseleit buffer was used (144 mm NaCl, 4.2 mm KCl, 1.6 mm MgCl 2 , 1.6 mm KH 2 PO 4 , 10 mm HEPES, pH 7.4) and Fe +3 (197 m)/ascorbate (19.7 mm) solutions were prepared in KrebsHenseleit buffer